Could a simple scan reveal which cancers are hiding a dangerous protein?
NCT ID NCT07301814
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new PET imaging probe that targets a protein called CLDN18.2, found in some stomach, pancreatic, bile duct, and esophageal cancers. Researchers will scan 56 people (patients and healthy volunteers) to see if the scan can accurately detect tumors and guide treatment choices. The goal is to improve diagnosis and help doctors decide who should receive CLDN18.2-targeted therapies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CLDN18.2-specific PET imaging probe (a radioactive tracer)
- What this could lead to
- If successful, this imaging method could help doctors better identify which patients might benefit from CLDN18.2-targeted therapies, improving personalized cancer treatment.
- What could go wrong
- This is an early-stage imaging study with only 56 participants, so results may not apply broadly. The tracer's safety and accuracy are still being evaluated.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Wuhan Union Hospital, China
RECRUITINGWuhan, Hubei, 430030, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a new infusion drug shrink Hard-to-Treat tumors?
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication